Challener, C. A. (2022). Managing mRNA Instability During Formulation, Manufacturing, and Shipment: Unique solutions are required to protect inherently unstable messenger RNA. Pharmaceutical Technology Europe, 34(12), 14-17.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Challener, Cynthia A. "Managing MRNA Instability During Formulation, Manufacturing, and Shipment: Unique Solutions Are Required to Protect Inherently Unstable Messenger RNA."
Pharmaceutical Technology Europe 34, no. 12 (2022): 14-17.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Challener, Cynthia A. "Managing MRNA Instability During Formulation, Manufacturing, and Shipment: Unique Solutions Are Required to Protect Inherently Unstable Messenger RNA."
Pharmaceutical Technology Europe, vol. 34, no. 12, 2022, pp. 14-17.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.